Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
136,917,771
-
Shares change
-
-2,082,430
-
Total reported value, excl. options
-
$747,537,873
-
Value change
-
-$24,940,455
-
Put/Call ratio
-
79%
-
Number of buys
-
78
-
Number of sells
-
-49
-
Price
-
$5.46
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2016
167 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q2 2016.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 136,917,771 shares
of 308,713,740 outstanding shares and own 44% of the company stock.
Largest 10 shareholders include FMR LLC (19,023,053 shares), PERCEPTIVE ADVISORS LLC (15,239,444 shares), Redmile Group, LLC (11,106,446 shares), VANGUARD GROUP INC (7,033,500 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,883,948 shares), BlackRock Fund Advisors (5,785,314 shares), JANUS CAPITAL MANAGEMENT LLC (5,562,366 shares), JENNISON ASSOCIATES LLC (5,147,214 shares), SECTORAL ASSET MANAGEMENT INC (4,788,738 shares), and STATE STREET CORP (4,480,616 shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.